Claude Ambroise

4.4k total citations
5 papers, 125 citations indexed

About

Claude Ambroise is a scholar working on Organic Chemistry, Physiology and Molecular Biology. According to data from OpenAlex, Claude Ambroise has authored 5 papers receiving a total of 125 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Organic Chemistry, 2 papers in Physiology and 1 paper in Molecular Biology. Recurrent topics in Claude Ambroise's work include Carbohydrate Chemistry and Synthesis (1 paper), Cholinesterase and Neurodegenerative Diseases (1 paper) and Cellular transport and secretion (1 paper). Claude Ambroise is often cited by papers focused on Carbohydrate Chemistry and Synthesis (1 paper), Cholinesterase and Neurodegenerative Diseases (1 paper) and Cellular transport and secretion (1 paper). Claude Ambroise collaborates with scholars based in United States and United Kingdom. Claude Ambroise's co-authors include Brian T. O’Neill, Michael A. Brodney, Charles E. Nolan, Christine Oborski, David Riddell, Jeffrey W. Brulet, Christopher Houle, Shawn D. Doran, Christopher W. am Ende and Cheng Chang and has published in prestigious journals such as Nature Communications, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Claude Ambroise

5 papers receiving 122 citations

Peers

Countries citing papers authored by Claude Ambroise

Since Specialization

Citations

This map shows the geographic impact of Claude Ambroise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude Ambroise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude Ambroise more than expected).

Fields of papers citing papers by Claude Ambroise

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claude Ambroise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude Ambroise. The network helps show where Claude Ambroise may publish in the future.

Co-authorship network of co-authors of Claude Ambroise

This figure shows the co-authorship network connecting the top 25 collaborators of Claude Ambroise. A scholar is included among the top collaborators of Claude Ambroise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claude Ambroise. Claude Ambroise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

#	Work	Indexed citations
1	Discovery of Small-Molecule CD33 Pre-mRNA Splicing Modulators 2022 ·ACS Medicinal Chemistry Letters ·Thomas A. Chappie, (unknown), Claude Ambroise, Markus Boehm, (unknown), Michael Green, Edward Guilmette, Claire M. Steppan, (unknown), Liuqing Wei, Simon Xi, Samuel A. Hasson	10
2	Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors 2016 ·Nature Communications ·Andrea M. Zuhl, Charles E. Nolan, Michael A. Brodney, Sherry Niessen, Kevin Atchison, Christopher Houle, David A. Karanian, Claude Ambroise, Jeffrey W. Brulet, Elizabeth M. Beck, Shawn D. Doran, Brian T. O’Neill, Christopher W. am Ende, Cheng Chang, Kieran F. Geoghegan, Graham M. West, Joshua C. Judkins, Xinjun Hou, David Riddell, Douglas S. Johnson	59
3	Tool Compounds Robustly Increase Turnover of an Artificial Substrate by Glucocerebrosidase in Human Brain Lysates 2015 ·PLoS ONE ·Zdenek Berger, Sarah E. Perkins, Claude Ambroise, Christine Oborski, Matthew F. Calabrese, Stephen Noell, David Riddell, Warren D. Hirst	11
4	P4–288: Effect of A673T mutation on APP processing by BACE1 and its significance for Alzheimer's disease therapeutic research 2013 ·Alzheimer s & Dementia ·Claude Ambroise, Rafael G. da Silva, Kevin Atchison, Gabriela Barreiro, Feng Pan, David Riddell	1
5	Spirocyclic Sulfamides as β-Secretase 1 (BACE-1) Inhibitors for the Treatment of Alzheimer’s Disease: Utilization of Structure Based Drug Design, WaterMap, and CNS Penetration Studies To Identify Centrally Efficacious Inhibitors 2012 ·Journal of Medicinal Chemistry ·Michael A. Brodney, Gabriela Barreiro, Kevin Ogilvie, Éva Hajós‐Korcsok, John C. Murray, F.F. Vajdos, Claude Ambroise, Curt Christoffersen, Katherine Fisher, Lorraine F. Lanyon, Jianhua Liu, Charles E. Nolan, Jane M. Withka, Kris A. Borzilleri, Ivan Efremov, Christine Oborski, Alison E. Varghese, Brian T. O’Neill	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact